Researchers need your help as they seek to better understand how lung cancer impacts people differently and how to improve treatment and quality of life. That’s why the GO2 Foundation for Lung Cancer started its Lung Cancer Registry. The international Lung Cancer Registry, available to join now, aims to double the 5-year survival rate of lung cancer patients from 20% to 40% by 2025. “By sharing your lung cancer story, contributing your experiences as a person with lung cancer or a caregiver of someone with lung cancer, you are helping the research community develop new treatments,” according to GO2. Let’s dive into more about the registry, how you can join, and how it can help Latinos.
Joining the Lung Cancer Registry
Participants interested in ...
“It was kind of a fluke.” That’s how Angelina Vazquez Felsing describes the events that led to her diagnosis of lung cancer. Like many, Vazquez Felsing maintained a healthy lifestyle. She didn’t smoke. She ate healthy, ran regularly, and had no family history of cancer. Vazquez Felsing, who immigrated from Mazatlán, Mexico, in 1972, grew up in the Floresville area and has lived in San Antonio for many years. It all started when Vazquez Felsing went to her yearly checkup through the wellness program at her job, where she has worked as a systems analyst for 17 years. “They found something that was a little bit odd. They said, ‘Well come back in a year, and we'll do another CT scan,’” she said. “And when I went back, they found that whatever ...
Colorectal cancer is a leading cause of cancer death among people of Hispanic and Latino descent in the United States. Adan Reinosa Rivera, a retired electrical engineer in Los Angeles, is doing his part to change that. Mr. Reinosa has been living with metastatic colorectal cancer for more than a decade. The cancer was detected in his lungs a few months after a tumor was removed from his colon. He’s been managing the disease with his doctor ever since. Now, as the first participant in a genetic study called ENLACEExit Disclaimer, Mr. Reinosa is helping to build a body of knowledge about the molecular features of colorectal cancers in Hispanic and Latino people. The study, supported by the Cancer MoonshotSM, aims to learn more about the disease in people of Hispanic and ...
A big challenge for cancer survivors is a disruption in "cognitive functioning." Stress can contribute to lapses in attention, memory, and other mental abilities that can limit a survivor's daily activities and ability to work. To help, researchers from UT Health San Antonio and UT San Antonio will test a 6-month therapeutic Yoga program — along with supportive text messages and dietary guidance — to improve cognitive functioning in 35 Latina and 35 non-Latina breast cancer survivors. The pilot project, "Surviving is Not Enough: Enhancing Cognitive Function in Cancer Survivors through Movement and Introspection," is led by Dr. Daniel Carlos Hughes, a researcher at the Institute for Health Promotion Research at UT Health San Antonio, and Dr. Joseph Houpt, professor of ...
Are you passionate about public health? The Institute for Health Promotion Research (IHPR) at UT Health San Antonio — home to the Salud America! program — is seeking a qualified senior research scientist with expertise in public health research. The position will focus on two IHPR projects: Avanzando Caminos (Leading Pathways): The Hispanic/Latino Cancer Survivorship Study
Avanzando Equidad de Salud: Latino Cancer Health Equity Research Center Apply here for the senior research scientist position. “Our goal is to find a passionate research scientist who can help us plan, coordinate, analyze, and produce scientific content for clinical and regulatory documents on these two important research projects,” said Dr. Amelie Ramirez, director of the IHPR and chair of ...
Parkinson’s disease is a brain disorder that causes uncontrollable movements, such as shaking, stiffness, and difficulty with balance, according to the National Institute on Aging. But what do you really know about Parkinson’s and your risk? Let’s dive into the causes, symptoms, and treatment of Parkinson’s and how it impacts Latinos.
What Causes Parkinson’s Disease?
Parkinson’s disease is a progressive and chronic nervous system disorder that affects movement and is caused by destroyed nerve cells in the brain. “A decrease in dopamine levels leads to abnormal brain activity, causing symptoms of Parkinson's disease. However, it is currently unknown what causes the death of neurons in the brain,” according to dementia.org. While the exact ...
UT Health San Antonio, including Dr. Amelie G. Ramirez, and seven regional collaborators will leverage $46 million from the National Institutes of Health (NIH) over the next five to seven years to translate scientific discoveries into therapeutic benefits for human health and well-being. A key focus will be reducing health disparities among Latinos (particularly Mexican Americans), active military personnel, and veterans. Dr. William L. Henrich, president of UT Health San Antonio, recently announced the funding from the NIH Clinical and Translational Science Awards (CTSA) Program. Henrich thanked partners including The University of Texas at Austin Dell Medical School and College of Pharmacy, The University of Texas at San Antonio and the Texas Biomedical Research Institute for ...
Researchers at The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio are recruiting participants for the VIVA-MIND study to learn whether a new drug therapy for Alzheimer’s disease can help people experiencing mild memory problems. Volunteers ages 50 to 89 with a diagnosis of mild cognitive impairment or probable mild Alzheimer’s may ask about eligibility for VIVA-MIND, said Dr. Sudha Seshadri, professor of neurology and director of the Glenn Biggs Institute. Half of volunteers will be given the new drug therapy, an oral pill called varoglutamstat. The other half will receive a placebo pill that looks just like the study drug. “The first people who will benefit from a new Alzheimer’s disease treatment are those who are ...
Most people with COVID-19 get better within a few days to a few weeks after COVID-19 infection. But some people, including many Latinos, develop long COVID. Long COVID remains an unresolved threat to the health of Latinos and all people. While health experts don’t yet fully understand long COVID symptoms and risk factors, progress is being made regarding treatment. Let’s learn more about how researchers are working to find the most effective therapies for long COVID through research studies and clinical trials.
Relieving the Burden of Long COVID Symptoms
The National Institutes of Health (NIH) launched the RECOVER research study in 2021 to learn why some people experience long COVID or develop new or returning symptoms after COVID-19 infection. Now, based on ...